71 filings
Page 2 of 4
424B5
r03rva7dxyi7ze
19 Apr 23
Prospectus supplement for primary offering
4:05pm
424B5
u8l yc32vpddc
18 Apr 23
Prospectus supplement for primary offering
9:21am
8-K
gto2n
18 Apr 23
Results of Operations and Financial Condition
9:04am
8-K
mlm2gxa1y9s510b
6 Mar 23
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
4:05pm
8-K
44z5kt
10 Nov 22
Immuneering Reports Third Quarter 2022 Financial Results and Recent Business Highlights
9:00am
8-K/A
qfp85
19 Sep 22
Departure of Directors or Certain Officers
4:30pm
EFFECT
7pkl uqmtt
22 Aug 22
Notice of effectiveness
12:15am
CORRESP
1b8rsu3gl my3
17 Aug 22
Correspondence with SEC
12:00am
UPLOAD
a91xl
17 Aug 22
Letter from SEC
12:00am
S-3
e9x640
10 Aug 22
Shelf registration
4:39pm
8-K
g2l6s8d2j d34texf
10 Aug 22
Immuneering Reports Second Quarter 2022 Financial Results and Recent Business Highlights
4:05pm
8-K
z4g3jmm7wvrg8
25 Jul 22
Departure of Directors or Certain Officers
7:00am
8-K
8fg4k
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
eizh4o
10 May 22
Immuneering Reports First Quarter 2022 Financial Results and Recent Business Highlights
6:32am
DEFA14A
wew80yeakiwqp 0zgb6k
2 May 22
Additional proxy soliciting materials
7:03am
DEF 14A
5ompr oayin0y
2 May 22
Definitive proxy
7:01am